Benito Novas, Global Stem Cells Group CEO Announces Opening of New Stem Cell Center in Valencia, Spain
The new center will continue the Global Stem Cells Group’s mission to expand access to stem cell therapies and training to physicians across the globe.
MIAMI LAKES, Florida—A new Stem Cell Center is set to open its doors in Spain. Benito Novas, CEO of the Global Stem Cells Group (GSCG), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, has announced the opening of the group’s Valencia, Spain center. The new clinic will be the group’s third operation in Spain and the fourth in Europe.
The Global Stem Cells Group’s Valencia center joins the already existing centers in , which include locations in Bruselas, Madrid, and Barcelona. With the opening of the new center, the GSCG will boast 41 such locations across the globe.
Novas noted that the group has been focusing its efforts on opening its cutting-edge Stem Cell Centers in Europe, in part due to the group’s recognition that regenerative medicine is a fast-growing field across the continent.
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.
“I am thrilled to lead the efforts at the Stem Cell Center in Valencia,” said Dra. Caicedo. “I am looking forward to utilizing cutting-edge therapy options based in stem cell science to help treat patients suffering from hair loss. Additionally, the opportunity is an exciting one given the Global Stem Cells Group’s excellent reputation and stature as the longest-standing and most respected stem cells network. I’m looking forward to learning from other physicians in the network across the globe and sharing my expertise with other practitioners in regenerative medicine.”
The GSCG will provide the Valencia center with the newest and most effective marketing tools in the field to help the franchise increase its performance in recruiting new patients.
Marketing support is one of the many benefits of joining the GSCG’s expanding global network of clinics. Being part of the group’s network gives physicians access to other experts within the its global network, add to their practice the newest regenerative medicine protocols, and have access to a proven marketing strategy developed by GSCG.
To learn more about the Global Stem Cells Group, visit http://www.stemcellsgroup.com/.
.
- Published in Press Releases
ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
The global group will hold its 6th International Regenerative Medicine Symposium in October 2019.
MIAMI LAKES, Florida—The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, has announced its 6th annual International Regenerative Medicine Symposium in Buenos Aires. The event will attract physicians from across the globe and will be held on October 12, 2019 in Buenos Aires, Argentina at the Hotel Panamericano.
The past five years of the ISSCA sponsored event have been a global success. This year’s meeting will feature educational sessions and product information and demonstrations, with a special focused placed on the newest compounds in the allogeneic stem cells market, including exosomes, amniotic fluid compounds, and cord blood products. With allogeneic compounds growing in popularity, safety, and treatment efficacy, ISSCA will give physicians the opportunity to learn more about them and how they can be incorporated into their practices.
A number of experts within the field of regenerative medicine are confirmed for the event and include.
• Dra. Maritza Novas, Chief of I&D, Global Stem Cells Group USA
• Dr. Leopoldo Paradas, President of Asociación Chilena de Ingeniería Tisular
• Dr. Matias Fernandez Vina Argentinian Cardiologist
“We are pleased to be hosting our popular International Regenerative Medicine Symposium for a sixth year,” said Benito Novas, CEO of ISSCA. “Each year our symposium focuses on critical topics and exciting breakthroughs in the field of regenerative medicine, and this year is no different as we seek to retain our position as a vanguard in the field.”
Physicians interested in registering for or learning more about the Buenos Aires symposium may visit https://www.issca.us/.
- Published in Press Releases
ISSCA Launches New Stem Cells Certification Course
The newly developed program gives physicians the opportunity to learn the latest methods and knowledge in the field of regenerative medicine.
MIAMI LAKES, Florida—The International Society for Stem Cells Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, has announced a new course for physicians interested in gaining certification in regenerative medicine. The course was developed out of the group’s highly successful global conference certifications, providing physicians a newly designed and more intimate and personalized smaller group training through which to gain critical skills and knowledge in the field of regenerative medicine.
Through completion of the certification course, physicians will learn how they can add cell-based product protocols to their existing medical practices, including those using exosomes, amniotic fluid, and cord blood.
A host of global experts practicing within the field will be on hand to lead attendees through the new training. They will share first-hand scientific information on the science behind cell therapies and cell-based products and their clinical applications. In-depth examination of clinical trials that demonstrate the safety and efficacy of cell-based products will also be part of the one-day training.
Physicians attending the certification will also learn how to distinguish between the most popular cellular products on the market and what factors to keep in mind when choosing stem cell protocols as a therapeutic alternative. Course faculty will additionally lead attendees through how to structure treatment plans and protocols for patients who may benefit from stem cell therapies.
“We are pleased to be able to offer this exciting and informative new training to physicians interested in adding stem cell treatment options to their current medical practices,” said Benito Novas, CEO of ISSCA. “We seek to remain at the forefront of the stem cells field by continuously innovating and offering the global community the training they need to deliver effective, cutting edge treatment options to their patients. We decided to offer this new training in part due to the demand for it from our customers, who are eager to expand their knowledge base and offer new treatment options to their patients.”
ISSCA has set four dates and locations for its new certification course, and this is the first time such certification has been held by the group outside of the United States:
• Santiago de Chile, Chile: September 5, 2019
• Bogota, Colombia: October 4, 2019
• Buenos Aires, Argentina: October 11, 2019
• Miami, Florida (in English): November 1, 2019
To learn more about ISSCA’s latest certification program and to register, or to learn more about ISSCA, visit https://www.issca.us/.
- Published in Press Releases
Global Stem Cells Group to offer Stem Cell Training Certification course Oct. 1 and 2, Following International Symposium in Buenos Aires
MIAMI, Sept. 13, 2016-Global Stem Cells Group announced plans to hold a stem cell training certification course Oct. 1 -2, 2016 following the 3rd annual Global Stem Cells Group International Symposium on Stem Cells and Regenerative Medicine in Buenos Aires. The symposium will take place Sept. 28, 2016.
The two-day, hands-on training course covers the latest technology and procedures in SVF and bone marrow stem cell techniques. Practitioners learn skills that can be used to treat patients in their practices, and for career advancement. The SVF and bone marrow aspiration course was developed for physicians and high-level practitioners to learn techniques in harvesting and rein
Joseph Purita, MD
tegrating stem cells derived from adipose tissue and bone marrow. The objective of the training teach effective, in-office regenerative medicine techniques.
Silvina Pastrana, M.D.
The course will be taught by GSCG Advisory Board members Joseph Purita, M.D. and Silvina Pastrana, M.D.
The stem cell training certification course will be held at the Global Subsidiary Stem Cell Center Network in Puerto Madero Buenos Aires immediately following the 3rd annual International Symposium on Stem Cells and Regenerative Medicine.
Since 2014, Global Stem Cells Group has joined forces with some of the most prestigious regenerative medicine practitioners in South America as it focuses on growing its services throughout the global community. Stem cell therapies continue to revolutionize the anti-aging aesthetics industry and help improve the quality of life for patients suffering from some chronic conditions.
To learn more about the 3rd Annual International Symposium on Stem Cells and Regenerative Medicine, visit the Global Stem Cells Group website, email bnovas(at)stemcellsgroup(dot)com, or call 305-560-5337.
About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
To view this press release live online, click here
###
- Published in Press Releases
- 1
- 2